Skip to main content
Home Home

User account menu

Log in

Main navigation

  • Home
  • Topics
    • Biological medicines
    • Cardiovascular disease
    • Equity
    • Focus medicines
    • Gout
    • Type 2 diabetes
  • Resources
    • All education/search
    • Events
    • HAH Bulletins
    • Podcasts
    • Recorded webinars
    • Reflection activities
    • Resource hubs
    • Videos
  • EPiC dashboard
    • Go to EPiC
    • Join EPiC
    • EPiC FAQ
    • EPiC Demo
    • About EPiC
    • Win with EPiC!
  • News
    • That's Interesting
    • From The Team

Education

  1. Home
  2. Search

The hub for all your learning resources.

Here you will find all our clinical education resources from articles to recorded webinars, all supporting equitable access to funded medicines.

Bulletin #1

Inequities in type 2 diabetes

1 minute to Read + 2 minutes to Delve

Health inequities in the detection and management of diabetes and its associated health outcomes are significant concerns in New Zealand. The first step to addressing inequitable health outcomes is knowing that they exist.

Read the HAH bulletin to find out more. 

Contributor
He Ako Hiringa
30 March 2021
  • HAH Bulletins
  • Equity
  • Diabetes

What's new with type 2 diabetes care in 2021?

65 minutes to Watch

In this webinar, Dr Ryan Paul discusses the changes to type 2 diabetes care in 2021, including when and how to use SGLT2 inhibitors and GLP-1 agonists. You can watch the webinar here or in ELearning. 

Downloadable empagliflozin patient information and a recent slide presentation can be found within this article.

Contributor
Dr Ryan Paul
4 March 2021
  • Diabetes
  • Recorded webinar

Can you say empagliflozin?

If you're having trouble pronouncing the name of the newly funded SGLT2 inhibitor for type 2 diabetes, you're not the only one! Watch our video guide to learn how to pronounce empagliflozin. 

Contributor
He Ako Hiringa
3 March 2021
  • Videos
  • Diabetes
Puzzle

New medicines for type 2 diabetes

10 minutes to Read

Inequities exist in all aspects of diabetes care. In this article, Alesha Smith outlines some examples, proposes some actions, and explains where the new medicines fit in. 

This activity has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 0.5 CME credits for the General Practice Educational Programme (GPEP) and Continuing Professional Development (CPD) purposes.

Contributor
Dr Alesha Smith
3 February 2021
  • Diabetes
  • Equity
Medications

Special Authority Quick Guide for SGLT2 inhibitors for type-2 diabetes

1 minute to Read

Late last year, PHARMAC announced the SGLT2 inhibitor empagliflozin (Jardiance®) and empagliflozin with metformin (Jardiamet®) will be funded for the treatment of type 2 diabetes under Special Authority.

Find out all you need to know about the Special Authority criteria. 

Contributor
He Ako Hiringa
25 January 2021
  • Diabetes

Introducing He Ako Hiringa and the EPiC Dashboard

37 minutes to Watch

In this webinar, Dr Alesha Smith discusses the development of He Ako Hiringa and presents our new interactive data tool, EPiC. You can watch this webinar here or in ELearning. 

Contributor
Dr Alesha Smith
16 December 2020
  • Recorded webinar

Inequities in diabetes

48 minutes to Watch

In this webinar, Dr Rinki Murphy discusses the issue of inequity in diabetes care. You can watch this webinar here or in ELearning. 

Contributor
Dr Rinki Murphy
4 December 2020
  • Equity
  • Diabetes
  • Recorded webinar

Improving medicine access equity in primary care

42 minutes to Watch

In this webinar, Sandy Bhawan and Dr Emily Gill discuss how to improve medicine access equity in primary care. You can watch this webinar here or in ELearning.

Contributor
Sandy Bhawan, Dr Emily Gill
17 November 2020
  • Equity
  • Recorded webinar
Working together to improve medicine access equity

A story of changing lives: Prescribing equity through better use of medicines

2 minutes to Read

The call for equity in healthcare is not new but it is louder than it has ever been before. This article shares the experiences of primary care clinicians around the country as they work to improve medicine access equity for patients. This article is part of a course, which is accredited by PSNZ for Group 2 points for pharmacists and endorsed by CNA(NZ) for 1.5 professional development hours for nurses. It is also suitable for professional development for general practitioners.

Contributor
Interviews by Michael Botur
22 October 2020
  • Equity

Medicine Access Equity: A call to action

23 minutes to Watch

Do you need help improving your understanding of medicine access equity issues? In this video you will hear from a number of primary healthcare professionals who are working to improve equity outcomes in the services they provide to patients

Contributor
He Ako Hiringa
20 October 2020
  • Equity
  • Videos

Pagination

  • « First First page
  • ‹ Previous Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Home Home

Contact Us

11 Omana Road, Milford Auckland NZ, 0620

PO Box 31905, Milford Auckland NZ, 0741

Support

09 488 4286

admin@akohiringa.co.nz

(9-5pm Mon-Fri)

Contact us

About us

Terms & Policies

  • Conditions for Use
  • Privacy Policy

Supported by

Pharmac

© Matui Limited. All rights reserved.

Developed by Matui Limited and brought to life by Communica.